Your browser doesn't support javascript.
loading
Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma.
Nyakas, M; Aamdal, E; Jacobsen, K D; Guren, T K; Aamdal, S; Hagene, K T; Brunsvig, P; Yndestad, A; Halvorsen, B; Tasken, K A; Aukrust, P; Maelandsmo, G M; Ueland, T.
Afiliación
  • Nyakas M; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.
  • Aamdal E; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Jacobsen KD; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.
  • Guren TK; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Aamdal S; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.
  • Hagene KT; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.
  • Brunsvig P; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Yndestad A; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.
  • Halvorsen B; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.
  • Tasken KA; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Aukrust P; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Maelandsmo GM; K.G. Jebsen Inflammatory Research Center, University of Oslo, Oslo, Norway.
  • Ueland T; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Clin Exp Immunol ; 197(1): 74-82, 2019 07.
Article en En | MEDLINE | ID: mdl-30821848
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ipilimumab / Antineoplásicos Inmunológicos / Melanoma Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Immunol Año: 2019 Tipo del documento: Article País de afiliación: Noruega
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ipilimumab / Antineoplásicos Inmunológicos / Melanoma Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Immunol Año: 2019 Tipo del documento: Article País de afiliación: Noruega